European bourses were mixed Wednesday, with techs lower and investors cautious
about US interest rates, while gains at Sanofi-Aventis lifted drug players.
The French pharmaceutical giant has reached agreement with generic drug firm
Apotex over blockbuster blood thinner Plavix. US patent protection could now
be in place until 2011.